|Bid||3.55 x 3400|
|Ask||3.70 x 50000|
|Day's Range||1.65 - 1.73|
|52 Week Range||1.63 - 2.55|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.60|
STABILITY OF NET LOSS MAJOR PROGRESS ON R&D PROGRAMS IN HEALTH, NUTRITION AND COSMETICS. ·Cash position:+ €6.6 m at June 30, 2017 compared to+ €9.3 m at December 31, 2016.· Half-year net loss of DEINOVE ...
The AGIR project carried out by the DEINOVE group is granted €14.6 million by the' Investments for the Future' Program operated by Bpifrance to develop new antibiotics.. The AGIR project, carried out by ...